292 related articles for article (PubMed ID: 15940068)
1. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
2. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
3. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.
Montemaggi P; Costamagna G; Dobelbower RR; Cellini N; Morganti AG; Mutignani M; Perri V; Brizi G; Marano P
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):437-43. PubMed ID: 7538501
[TBL] [Abstract][Full Text] [Related]
4. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
Montemaggi P; Morganti AG; Dobelbower RR; Brizi G; Smaniotto D; Costamagna G; Cellini N; Marano P
Radiology; 1996 Jun; 199(3):861-6. PubMed ID: 8638018
[TBL] [Abstract][Full Text] [Related]
5. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.
Ishii H; Furuse J; Nagase M; Kawashima M; Ikeda H; Yoshino M
Hepatogastroenterology; 2004; 51(58):954-7. PubMed ID: 15239222
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: a pilot study.
Singh V; Kapoor R; Solanki KK; Singh G; Verma GR; Sharma SC
Liver Int; 2007 Apr; 27(3):347-52. PubMed ID: 17355456
[TBL] [Abstract][Full Text] [Related]
8. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas.
Dvorák J; Jandík P; Melichar B; Jon B; Mergancová J; Zoul Z; Vacek Z; Petera J
Hepatogastroenterology; 2002; 49(46):916-7. PubMed ID: 12143240
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
10. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
Mutignani M; Shah SK; Morganti AG; Perri V; Macchia G; Costamagna G
Endoscopy; 2002 Jul; 34(7):555-9. PubMed ID: 12170409
[TBL] [Abstract][Full Text] [Related]
11. Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma.
Lo SS; Wu CW; Chi KH; Tseng HS; Shen KH; Hsieh MC; Lui WY
Cancer; 2000 Jul; 89(1):29-34. PubMed ID: 10896997
[TBL] [Abstract][Full Text] [Related]
12. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies--the question of long-term palliation.
Bruha R; Petrtyl J; Kubecova M; Marecek Z; Dufek V; Urbanek P; Kodadova J; Chodounsky Z
Hepatogastroenterology; 2001; 48(39):631-7. PubMed ID: 11462891
[TBL] [Abstract][Full Text] [Related]
13. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
Fuks D; Bartoli E; Delcenserie R; Yzet T; Celice P; Sabbagh C; Chatelain D; Joly JP; Cheron N; Dupas JL; Regimbeau JM
J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885
[TBL] [Abstract][Full Text] [Related]
14. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
Eschelman DJ; Shapiro MJ; Bonn J; Sullivan KL; Alden ME; Hovsepian DM; Gardiner GA
Radiology; 1996 Sep; 200(3):717-24. PubMed ID: 8756921
[TBL] [Abstract][Full Text] [Related]
15. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG
Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935
[TBL] [Abstract][Full Text] [Related]
16. Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report.
Macchia G; Costamagna G; Morganti AG; Mutignani M; Giuliante F; Clemente G; Deodato F; Smaniotto D; Mattiucci GC; Sallustio G; Valentini V; Nuzzo G; Cellini N
Dig Liver Dis; 2005 Aug; 37(8):615-8. PubMed ID: 15890567
[TBL] [Abstract][Full Text] [Related]
17. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial.
Soderlund C; Linder S
Gastrointest Endosc; 2006 Jun; 63(7):986-95. PubMed ID: 16733114
[TBL] [Abstract][Full Text] [Related]
18. [Metallic mesh endoprosthesis and intraluminal high dose rate 192Ir brachytherapy in the palliative treatment of malignant bile duct obstruction. Initial results].
Pakisch B; Klein GE; Stücklschweiger G; Lammer J; Poier E; Leitner H; Poschauko J; Hausegger KA; Hackl A
Rofo; 1992 Jun; 156(6):592-5. PubMed ID: 1377518
[TBL] [Abstract][Full Text] [Related]
19. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting.
Brountzos EN; Ptochis N; Panagiotou I; Malagari K; Tzavara C; Kelekis D
Cardiovasc Intervent Radiol; 2007; 30(1):66-73. PubMed ID: 17031733
[TBL] [Abstract][Full Text] [Related]
20. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts.
Shin HS; Seong J; Kim WC; Lee HS; Moon SR; Lee IJ; Lee KK; Park KR; Suh CO; Kim GE
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):105-12. PubMed ID: 12909222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
